Samarth Kulkarni insider trades: CRISPR Therapeutics (CRSP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Samarth reports to the SEC
Open-market buys and sales
50 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | CRSP | ↓ Sell | 47,837 | $49.78 | $2.4M | Direct | Oct 20, 2026 (1d) |
| Oct 14, 2026 | CRSP | ↓ Sell | 4,098 | $49.26 | $202K | Direct | Oct 15, 2026 (1d) |
| Mar 23, 2026 | CRSP | ↓ Sell | 10,020 | $46.78 | $469K | Direct | Mar 24, 2026 (1d) |
| Mar 16, 2026 | CRSP | ↓ Sell | 10,349 | $48.26 | $499K | Direct | Mar 17, 2026 (1d) |
| Mar 11, 2026 | CRSP | ↓ Sell | 9,798 | $52.80 | $517K | Direct | Mar 12, 2026 (1d) |
| Feb 19, 2026 | CRSP | ↓ Sell | 6,967 | $52.58 | $366K | Direct | Feb 20, 2026 (1d) |
| Jan 22, 2026 | CRSP | ↓ Sell | 90,000 | $57.40 | $5.2M | Direct | Jan 22, 2026 (0d) |
| Oct 17, 2025 | CRSP | ↓ Sell | 50,895 | $67.91 | $3.5M | Direct | Oct 20, 2025 (3d) |
| Oct 14, 2025 | CRSP | ↓ Sell | 4,242 | $66.60 | $283K | Direct | Oct 15, 2025 (1d) |
| Aug 18, 2025 | CRSP | ↓ Sell | 13,081 | $58.15 | $761K | Direct | Aug 19, 2025 (1d) |
| Mar 21, 2025 | CRSP | ↓ Sell | 10,031 | $41.23 | $414K | Direct | Mar 24, 2025 (3d) |
| Mar 12, 2025 | CRSP | ↓ Sell | 14,435 | $42.70 | $616K | Direct | Mar 12, 2025 (0d) |
| Feb 19, 2025 | CRSP | ↓ Sell | 18,360 | $55.20 | $1.0M | Direct | Feb 21, 2025 (2d) |
| Feb 19, 2025 | CRSP | ↓ Sell | 18,568 | $54.21 | $1.0M | Direct | Feb 19, 2025 (0d) |
| Dec 2, 2024 | CRSP | ↓ Sell | 15,000 | $55.10 | $827K | Direct | Dec 4, 2024 (2d) |
| Nov 11, 2024 | CRSP | ↓ Sell | 30,000 | $55.62 | $1.7M | Direct | Nov 13, 2024 (2d) |
| Oct 14, 2024 | CRSP | ↓ Sell | 4,293 | $46.28 | $199K | Direct | Oct 15, 2024 (1d) |
| Apr 15, 2024 | CRSP | ↓ Sell | 19,582 | $59.91 | $1.2M | Direct | Apr 17, 2024 (2d) |
| Mar 15, 2024 | CRSP | ↓ Sell | 20,000 | $72.48 | $1.4M | Direct | Mar 18, 2024 (3d) |
| Mar 12, 2024 | CRSP | ↓ Sell | 14,385 | $77.04 | $1.1M | Direct | Mar 12, 2024 (0d) |
| Feb 20, 2024 | CRSP | ↓ Sell | 6,370 | $79.67 | $507K | Direct | Feb 21, 2024 (1d) |
| Feb 15, 2024 | CRSP | ↓ Sell | 20,000 | $80.36 | $1.6M | Direct | Feb 16, 2024 (1d) |
| Jan 29, 2024 | CRSP | ↓ Sell | 50,000 | $60.51 | $3.0M | Direct | Jan 31, 2024 (2d) |
| Jan 16, 2024 | CRSP | ↓ Sell | 20,000 | $62.50 | $1.3M | Direct | Jan 18, 2024 (2d) |
| May 30, 2023 | CRSP | ↓ Sell | 25,000 | $64.88 | $1.6M | Direct | Jun 1, 2023 (2d) |
| Apr 25, 2023 | CRSP | ↓ Sell | 25,000 | $50.67 | $1.3M | Direct | Apr 27, 2023 (2d) |
| Mar 29, 2023 | CRSP | ↓ Sell | 25,000 | $44.46 | $1.1M | Direct | Mar 31, 2023 (2d) |
| Feb 27, 2023 | CRSP | ↓ Sell | 25,000 | $48.25 | $1.2M | Direct | Mar 1, 2023 (2d) |
| Jan 27, 2023 | CRSP | ↓ Sell | 25,000 | $51.47 | $1.3M | Direct | Jan 31, 2023 (4d) |
| Dec 28, 2022 | CRSP | ↓ Sell | 25,000 | $40.93 | $1.0M | Direct | Dec 30, 2022 (2d) |
| Nov 28, 2022 | CRSP | ↓ Sell | 25,000 | $54.03 | $1.4M | Direct | Nov 30, 2022 (2d) |
| Oct 26, 2022 | CRSP | ↓ Sell | 25,000 | $54.81 | $1.4M | Direct | Oct 28, 2022 (2d) |
| Sep 28, 2022 | CRSP | ↓ Sell | 25,000 | $64.61 | $1.6M | Direct | Sep 30, 2022 (2d) |
| Aug 29, 2022 | CRSP | ↓ Sell | 25,000 | $66.84 | $1.7M | Direct | Aug 31, 2022 (2d) |
| Jul 27, 2022 | CRSP | ↓ Sell | 25,000 | $75.91 | $1.9M | Direct | Jul 29, 2022 (2d) |
| Jun 29, 2022 | CRSP | ↓ Sell | 25,000 | $61.59 | $1.5M | Direct | Jul 1, 2022 (2d) |
| Aug 5, 2021 | CRSP | ↓ Sell | 28,500 | $128.98 | $3.7M | Direct | Aug 6, 2021 (1d) |
| Aug 4, 2021 | CRSP | ↓ Sell | 1,500 | $125.02 | $188K | Direct | Aug 6, 2021 (2d) |
| Jun 15, 2021 | CRSP | ↓ Sell | 30,000 | $126.43 | $3.8M | Direct | Jun 17, 2021 (2d) |
| Jan 15, 2021 | CRSP | ↓ Sell | 20,000 | $213.67 | $4.3M | Direct | Jan 20, 2021 (5d) |
| Dec 10, 2020 | CRSP | ↓ Sell | 20,000 | $142.29 | $2.8M | Direct | Dec 11, 2020 (1d) |
| Jun 1, 2020 | CRSP | ↓ Sell | 17,275 | $64.68 | $1.1M | Direct | Jun 3, 2020 (2d) |
| May 20, 2020 | CRSP | ↓ Sell | 15,000 | $65.25 | $979K | Direct | May 21, 2020 (1d) |
| Jun 17, 2019 | CRSP | ↓ Sell | 20,000 | $46.00 | $920K | Direct | Jun 19, 2019 (2d) |
| Apr 29, 2019 | CRSP | ↓ Sell | 20,000 | $42.03 | $841K | Direct | May 1, 2019 (2d) |
| Jun 1, 2018 | CRSP | ↓ Sell | 15,000 | $69.36 | $1.0M | Direct | Jun 5, 2018 (4d) |
| Aug 30, 2017 | CRSP | ↓ Sell | 27,154 | $20.08 | $545K | Direct | Aug 30, 2017 (0d) |
| Apr 27, 2017 | CRSP | ↓ Sell | 5,481 | $16.76 | $92K | Direct | Apr 28, 2017 (1d) |
| Apr 25, 2017 | CRSP | ↓ Sell | 11,615 | $16.78 | $195K | Direct | Apr 25, 2017 (0d) |
| Apr 20, 2017 | CRSP | ↓ Sell | 10,058 | $17.73 | $178K | Direct | Apr 21, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRSP insiders
Open-market trades in the last 12 months
About Samarth Kulkarni's insider trades
Samarth Kulkarni is Chief Executive Officer at CRISPR Therapeutics (CRSP). Since Apr 20, 2017, Samarth has reported no open-market purchases and 50 sales worth $67.6M on SEC Form 4. In the last 12 months: 7 sales ($9.6M).
Their filings also include option exercises (58 filings), grants and awards (39 filings), shares withheld for taxes (21 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRSP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.